NCT01257503

Brief Summary

A randomized controlled trial of a commercially available homeopathic cold remedy will be conducted. A total of 400 children, 2-5 years old, diagnosed with an upper respiratory tract infection will be randomized to receive either the homeopathic remedy or placebo. Parents of study children will administer 5 ml of the study medication up to 6 times per day as needed to treat cold symptoms. One hour after giving a dose the parent will rate change in symptoms (for up to the first 10 doses). In addition, parents will rate their child's overall symptom severity and functional status over the first 3 days of the cold. It is postulated that children receiving the active homeopathic remedy will have better symptom relief and that their symptom severity and functional status will improve more rapidly than those receiving placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
263

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 9, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

January 2, 2015

Completed
Last Updated

January 14, 2015

Status Verified

December 1, 2014

Enrollment Period

2.7 years

First QC Date

December 8, 2010

Results QC Date

December 9, 2014

Last Update Submit

December 31, 2014

Conditions

Keywords

childrenupper respiratory tract infectionshomeopathy

Outcome Measures

Primary Outcomes (1)

  • Change in Severity of Cold Symptoms

    Parents measured change in runny nose, cough, nasal congestion and sneezing severity one hour after administering a dose of study medication up to the first 10 doses of study medication. Change in symptom rated from 0 to 6, with 0 indicative of the symptom being much worse and 6 indicative of the symptom being much improved. The unit of analysis for each outcome was doses of medication. Each participant could contribute data on 0 - 10 doses.

    Parents assessed change in symptom 1 hour after a dose of study medication

Secondary Outcomes (4)

  • Change in Non-specific Symptoms

    Parents assessed change in symptom 1 hour after dose of study medication

  • Functional Status

    10 days

  • Health Status

    10 days

  • Overall Symptom Severity

    10 days

Study Arms (2)

Homeopathic cold remedy

EXPERIMENTAL

5 ml of homeopathic cold remedy given by mouth up to 6 times per day as needed for cold symptoms

Drug: Hyland's Cold 'n Cough 4 kids

placebo

PLACEBO COMPARATOR

5 ml of placebo given by mouth up to 6 times per day as needed for cold symptoms

Drug: placebo

Interventions

5 ml PO q4h prn cold symptoms

Homeopathic cold remedy

liquid made to look like the active homeopathic remedy

placebo

Eligibility Criteria

Age2 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • clinical diagnosis of upper respiratory tract infection
  • duration of symptoms \< 7 days
  • Parent who speaks English

You may not qualify if:

  • history of asthma
  • on any prescribed medication
  • prescribed any medication other than acetaminophen or ibuprofen at index visit
  • use of homeopathic remedy within 48 hours of index visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Medical Center- Roosevelt Pediatric Care Center

Seattle, Washington, 98105, United States

Location

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Results Point of Contact

Title
James A Taylor
Organization
University of Washington

Study Officials

  • James A Taylor, MD

    University of Washington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 8, 2010

First Posted

December 9, 2010

Study Start

December 1, 2010

Primary Completion

August 1, 2013

Study Completion

December 1, 2013

Last Updated

January 14, 2015

Results First Posted

January 2, 2015

Record last verified: 2014-12

Locations